Viking Global Investors

Viking Global Investors is a leading global investment management firm founded in 1999 by Ole Andreas Halvorsen and partners. It manages over $50 billion across public equities (long-short and long-only), private equity—including significant activity in healthcare/life sciences—and credit strategies. The firm's dedicated healthcare team has invested over $3.5 billion into more than 70 healthcare-related companies since inception. While not itself a drug developer or life science company, it plays a major role funding innovation across biotech, medtech, digital health, and related fields—often participating from early stages through IPOs of its portfolio firms.